ctrl K

Price Alert

Amryt Pharma (AMYT)

NASDAQ: AMYT · Real-Time Price · USD

14.70

0.00 (0.00%)

At close: Jan 16, 2025, 10:00 PM

Amryt Pharma Revenue Breakdown

Period Ending	Dec 31, 2021
Mycapssa Revenue	6.41M
Mycapssa Revenue Growth	n/a

Revenue by Geography

Period Ending	Dec 31, 2021	Dec 31, 2020
Europe Middle East And Africa Revenue	81.14M	59.4M
Europe Middle East And Africa Revenue Growth	+36.59%	n/a
Other Countries Revenue	31.88M	25.32M
Other Countries Revenue Growth	+25.92%	n/a

Operating Expense Breakdown

Period Ending	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Selling, General, and Administrative Revenue	29.88M	31.11M	30.86M	31.99M	28.39M	23.98M	19.42M	21.38M	18.42M	22.45M	19.15M	20.07M	6.1M	6.18M	3.99M
Selling, General, and Administrative Revenue Growth	-3.97%	+0.83%	-3.55%	+12.67%	+18.40%	+23.50%	-9.18%	+16.07%	-17.93%	+17.21%	-4.60%	+229.30%	-1.39%	+55.05%	n/a
Research and Development Revenue	8.01M	10.67M	9.88M	9.28M	11M	8.54M	8.92M	5.14M	7.35M	6.2M	8.93M	8.2M	2.41M	3.71M	1.5M
Research and Development Revenue Growth	-24.98%	+7.99%	+6.53%	-15.68%	+28.84%	-4.24%	+73.56%	-30.11%	+18.61%	-30.64%	+9.02%	+239.48%	-34.99%	+146.71%	n/a
Sales and Marketing Revenue	26.98M	n/a	27.71M	29.56M	25.71M	22.03M	18.16M	19.79M	16.89M	21.59M	18.41M	19.55M	6M	6.05M	3.9M
Sales and Marketing Revenue Growth	n/a	-100.00%	-6.25%	+14.98%	+16.69%	+21.33%	-8.26%	+17.18%	-21.77%	+17.29%	-5.86%	+225.92%	-0.86%	+55.31%	n/a